This site is no longer being updated. Data are accurate as of 2 Dec 2022.

Bagheiat-allah University of Medical Sciences: Noora vaccine

Bagheiat-allah University of Medical Sciences: Noora vaccine

Vaccine Type: Protein Subunit

This vaccine may also be referred to as COVID-19 Recombinant RBD Protein Vaccine

About Trial Phases

Phase 1: 1 Trial

IRCT20210620051639N1
Iran (Islamic Republic of)

Phase 2: 1 Trial

IRCT20210620051639N2
Iran (Islamic Republic of)

Phase 3: 1 Trial

IRCT20210620051639N3
Iran (Islamic Republic of)

Approvals

1 Country

Iran (Islamic Republic of)

Registered Trials

IRCT20210620051639N3
Phase 3
Iran (Islamic Republic of)
Total Enrollment: 10,300
Official Trial Registration:
- IRCT20210620051639N3(Opens in new tab/window)
IRCT20210620051639N2
Phase 2
Iran (Islamic Republic of)
Total Enrollment: 300
Official Trial Registration:
- IRCT20210620051639N2(Opens in new tab/window)
IRCT20210620051639N1
Phase 1
Iran (Islamic Republic of)
Total Enrollment: 70
Official Trial Registration:
- IRCT20210620051639N1(Opens in new tab/window)

© 2023 VIPER Group COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form